血管活性药物在心力衰竭治疗中的应用
被引量:1
Vasoactive drugs in treatment of heart failure
摘要
1 概述 急性心力衰竭常危及生命, 我国部分医院调查,急性心力衰竭占住院心血管病患者的16.3%~17.9%,心力衰竭病因主要为冠心病、入院时心功能都以Ⅲ级居多。基本为慢性心力衰竭的急性加重。急性左心力衰竭患者需紧急和积极治疗,本文参考我国急性心力衰竭指南介绍血管活性药物的应用规范。
出处
《中国医学前沿杂志(电子版)》
2010年第1期16-19,共4页
Chinese Journal of the Frontiers of Medical Science(Electronic Version)
参考文献8
-
1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
-
2Nieminen MS,Bohm M,Cowie MR,et al.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. European Heart Journal . 2005
-
3Follath F,Cleland JG,Just H,et al.Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet,The . 2002
-
4Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). European Heart Journal . 2002
-
5Hunt SA,Abraham WT,Chin MH,et al.2009 focused update incorporatedinto the ACC/AHA 2005 Guidelines for the Diagnosis and Management ofHeart Failure in Adults:a report of the American College of Cardiology Foun-dation/American Heart Association Task Force on Practice Guidelines:devel-oped. Circulation . 2009
-
6Yancy CW,Singh A.Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial). The American Journal of Cardiology . 2006
-
7Cuffe MS,Califf RM,Adams KF Jr,et al.For the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure(OPTIME-CHF)investigations Short-term intravenous milrinone for acute exacerbation of chronic heart failure:a randomized controlled trial. Journal of the American Medical Association, The . 2002
-
8Yancy CW,Krum H,Massie BM,et al.The second followup serial infusionsof nesiritide(FUSIONⅡ)trial for advanced heart failure:study rationale anddesign. American Heart Journal . 2007
二级参考文献9
-
1Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
-
2Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
-
3Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
-
4Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
-
5Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
-
6de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
-
7Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.
-
8de Denus S,Pharand C,Williamson DR.Brain natriuretic peptide in the management of heart failure:the versatile neurohormone.Chest,2004,125:652-668.
-
9Colucci WS.Nesiritide for the treatment of decompensated heart failure.J Card Fail,2001,7:92-100.
共引文献227
-
1王栓,齐腊梅,黄灿.某院重组人脑利钠肽药物利用评价标准的建立与应用[J].中国临床药学杂志,2023,32(11):807-813.
-
2李徽.重组人脑利钠肽在治疗35例急性心力衰竭的临床效果观察[J].医学信息(医学与计算机应用),2014,0(18):559-559.
-
3李志萍.浅谈难治性心衰临床治疗方法[J].黑龙江医学,2013,37(9):907-910. 被引量:1
-
4段海峰.重组人脑利钠肽治疗慢性心力衰竭急性发作50例临床观察[J].吉林医学,2013,34(13):2415-2416. 被引量:1
-
5袁龙,郝文君,李占全.脑利钠肽在急性冠脉综合征临床应用的研究进展[J].中国实用内科杂志,2007,27(12):979-981. 被引量:15
-
6王震,曹斌.重组人脑利钠肽治疗失代偿性心力衰竭进展[J].内科,2007,2(3):405-406. 被引量:4
-
7袁方,潘欣,倪幼方,王涛,陆静,蒋锦琪,方唯一.重组人脑利钠肽改善急性失代偿性心力衰竭患者早期心功能[J].上海交通大学学报(医学版),2007,27(7):853-855. 被引量:14
-
8吴红斌,冯国和.脑利钠肽治疗心力衰竭的护理[J].护理与康复,2007,6(9):642-643. 被引量:1
-
9林毅,吴同果.奈西立肽治疗急性心力衰竭的研究进展[J].中国心血管杂志,2007,12(5):394-396. 被引量:4
-
10张丽伟,罗北捷,宋岩,黄党生,沈东,张许文.重组人脑利钠肽治疗急性失代偿性心力衰竭的疗效及安全性[J].药物不良反应杂志,2007,9(5):316-319. 被引量:4
同被引文献10
-
1戴秋艳,吴莹.正性肌力药物在心力衰竭治疗中的应用[J].中国医刊,2006,41(5):18-21. 被引量:12
-
2胡大一,杨士伟,闫明珠,李媛,黄宏星.2005年欧洲心脏病学会急性心力衰竭诊断和治疗指南介绍(3)[J].中国医药导刊,2006,8(3):230-233. 被引量:3
-
3James KB,Militello M,Gus B,阳元彬(摘译),马康华(校).双室起搏治疗心力衰竭病人的正性肌力药物支持[J].心血管病学进展,2006,27(6):810-810. 被引量:1
-
4卢永昕.急性心力衰竭的治疗原则及临床处理[J].中国实用内科杂志,2007,27(9):650-651. 被引量:5
-
5蒋涛,李德才,刘思泰.2038 例慢性心力衰竭住院患者药物治疗动态分析[J].中国现代医学杂志,2011,12(05):65-66.
-
6陈津.急性心力衰竭综合症的早期处理建议[J].岭南心血管病杂志,2010,15(06):84-85.
-
7李从圣,程立顺.急性心力衰竭的现状及治疗进展[J].心血管病学进展,2009,30(4):679-682. 被引量:6
-
8曹洁玮,李小鹰.老年收缩性心力衰竭的药物治疗[J].国际心血管病杂志,2009,36(5):281-283. 被引量:6
-
9陈青华,陈丽娟.重症慢性心力衰竭患者的个体化药物治疗与经济性分析[J].中国药业,2010,19(1):51-52. 被引量:5
-
10李为民.急性心力衰竭诊断和治疗最新进展[J].中国实用内科杂志,2010,30(3):200-202. 被引量:31
-
1施冰.半乳糖凝集素-3与心力衰竭的临床研究进展[J].中华保健医学杂志,2013,15(6):535-537. 被引量:1
-
2肖小六.呼吸机相关肺炎的研究进展[J].临床内科杂志,2012,29(3):209-211. 被引量:11
-
3安文忠,贾永成.高龄患者电子胃镜检查的心理护理体会[J].中国医学创新,2011,8(32):78-79. 被引量:1
-
4陈春香,曹春芳,宋彩霞.西洛他唑联合前列地尔治疗对2型糖尿病合并下肢动脉病变患者血清炎症因子 踝/肱指数及血液流变学的影响[J].中国药物与临床,2013,13(6):761-763. 被引量:14
-
5彭春兰,邓惠英,罗梅银.高龄患者呼吸机相关性肺炎的呼吸护理对策[J].中国医药导刊,2012,14(3):499-500. 被引量:13
-
6章慧芳.呼吸机相关肺炎的发病因素分析及预防对策[J].现代护理,2002,8(10):819-820. 被引量:21
-
7游柳婵,姚瑞霞,叶宛华.妊娠期糖尿病患者不同时期血糖监测及胰岛素应用[J].中国医药科学,2012,2(4):58-59. 被引量:1
-
8王忠壮.高血压患者用药注意事项[J].家庭用药,2010(1):46-46.
-
9刘贵,胡立波.老年冠心病心绞痛应用规范方案治疗效果观察[J].航空航天医学杂志,2014,25(6):801-802. 被引量:1
-
10何俐.抗血小板治疗在卒中预防中的应用规范与实践[J].中华医学信息导报,2015,0(14):22-22.